Search Results - "GARETTO, Ferdinando"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Immune Checkpoint Inhibitors and Opioids in Patients with Solid Tumours: Is Their Association Safe? A Systematic Literature Review by Cani, Massimiliano, Bironzo, Paolo, Garetto, Ferdinando, Buffoni, Lucio, Cotogni, Paolo

    Published in Healthcare (Basel) (30-12-2022)
    “…Immune checkpoint inhibitors (ICIs) represent one of the most effective treatments for patients with cancer. As their activity relies on host immune system…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Palliative Sedation for the Terminally Ill Patient by Garetto, Ferdinando, Cancelli, Ferdinando, Rossi, Romina, Maltoni, Marco

    Published in CNS drugs (01-10-2018)
    “…Palliative sedation (PS) is performed in the terminally ill patient to manage one or more refractory symptoms. Proportional PS, which means that drugs can be…”
    Get full text
    Journal Article
  4. 4

    Weekly Irinotecan Plus Protracted Venous Fluorouracil Infusion (WI-FI) in Advanced Colorectal Cancer: A Phase II Study by OLIVA, Cristiano, POCHETTINO, Paolo, COMANDONE, Alessandro, BERGNOLO, Paola, BOGLIONE, Antonella, CHIADO CUTIN, Simona, INGUI, Manuela, DAL CANTON, Orietta, GARETTO, Ferdinando, BISCARDI, Manuela, BERNO, Elisa

    Published in Anticancer research (01-07-2008)
    “…Background: Irinotecan (IRI) is a topoisomerase I inhibitor active as first- or second-line chemotherapy in advanced colorectal cancer (ACRC). Its combination…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Metastatic soft tissue sarcomas (STS) in elderly patients: 18 years of monoinstitutional experience by Comandone, Alessandro, Boglione, Antonella, Giubellino, Elena, Bergnolo, Paola, chiadò Cutin, Simona, Dal Canton, Orietta, Garetto, Ferdinando, Ottaviani, Davide, Piana, Raimondo, Pochettino, Paolo, Prati, Veronica

    Published in Journal of clinical oncology (20-05-2017)
    “…Abstract only e22528 Background: Elderly people represent more than 50% of STS patients, but few data are available in this population and old patients in…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14